Skip to main content

Ferdenzi Paul J's Form 4 filing

Curtiss Wright Corp (CW) · filed Mar 17, 2022

Accession no.
0001628280-22-006561
Filed
Mar 17, 2022
Trade date
Mar 15-17, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $121.0K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ferdenzi Paul JCIK 0001535155Officer (Vice President and Corp. Sec.)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 15, 2022Common StockCConversionAcquired+1,849$144.85F2+$267,827.6515,867Direct
Mar 15, 2022Common StockSSaleDisposed−836$144.78F4−$121,036.0815,031Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 15, 2022Common StockCConversionDisposed−1,849$0.00F5$010,229Direct
Mar 17, 2022Common StockAGrant or awardAcquired+1,609$0.00F5$011,838Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Price is based on the closing price on of the Issuers securities as reported on the New York Stock Exchange for March 14, 2022, the date the award vested.

Referenced by the price of 1 transaction in Table I.

F4

Average sales price for all shares sold on March 15, 2022

Referenced by the price of 1 transaction in Table I.

F5

No price on the date of issue, option having been granted as an employee benefit transaction.

Referenced by the price of 2 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)